CTOs on the Move

Phathom Pharmaceuticals

www.phathompharma.com

 
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Phathom Pharmaceuticals raised $50M on 05/15/2019
Phathom Pharmaceuticals raised $90M on 05/15/2019

Similar Companies

Falks Woodland Pharmacy

Falks Woodland Pharmacy, Inc. is a Duluth, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eastpointe

Eastpointe is a Managed Care Organization (MCO) that manages, coordinates, and monitors mental health, intellectual and developmental disabilities, and substance addiction services in the Eastpointe region. We work together with individuals, families, ...

Windgap Medical

Windgap Medical is developing health care products that meet the demands of your lifestyle. Our first product will improve the quality of life for patients living with severe allergies.

Banziger Systems

Banziger Systems is a Emeryville, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Validation Resources

Validation Resources is a Bend, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.